Takeda Pharmaceutical News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

22.11.24	HUTCHMED To Receive Milestone Payment As Takeda Launches FRUZAQLA For Colorectal Cancer In Japan (RTTNews)
31.10.24	Takeda H1 Profit Rises; Upgrades 2024 Management Guidance (RTTNews)
24.06.24	Takeda Announces Approval Of LIVTENCITY In Japan - Quick Facts (RTTNews)
18.06.24	Takeda Presents Long-Term Data From Phase 3 ADVANCE-CIDP 3 Trial Of HYQVIA In CIDP Patients (RTTNews)
07.06.24	Former Takeda Employee Pleads Guilty To $2.3 Mln Embezzlement Scheme (RTTNews)
26.04.24	Takeda Reports Positive CHMP Opinion For Fruquintinib - Quick Facts (RTTNews)
22.04.24	Takeda, Astellas, Sumitomo Mitsui Banking To Form JV For Incubation Of Early Drug Discovery Programs (RTTNews)
19.04.24	FDA Approves Subcutaneous Administration Of Takeda's Entyvio For Crohn's Disease (RTTNews)
26.03.24	Takeda Announces Approval Of ADZYNMA Intravenous Injection 1500 In Japan (RTTNews)
20.03.24	Scilex, Takeda Settle Paragraph IV Patent Infringement Lawsuit - Quick Facts (RTTNews)
20.03.24	Takeda : FDA Approves SNDA For Iclusig In Adult Patients With Newly Diagnosed Ph+ ALL (RTTNews)
13.03.24	Takeda: Mezagitamab Phase 2 Trial Shows Positive Results In Primary Immune Thrombocytopenia (RTTNews)
27.02.24	Takeda Signs Manufacturing Partnership With India's Biological E. For Dengue Vaccine QDENGA (RTTNews)
12.02.24	Takeda Says FDA Approves EOHILIA To Treat Eosinophilic Esophagitis (RTTNews)
30.01.24	HUTCHMED Announces Marketing Approval For ELUNATE By Pharmacy And Poisons Board Of Hong Kong (RTTNews)
29.01.24	Takeda's Hyqvia Approved In Europe For Chronic Inflammatory Demyelinating Polyneuropathy (RTTNews)
16.01.24	Takeda Announces FDA Approval Of HYQVIA For CIDP - Quick Facts (RTTNews)
22.12.23	China Approves Takeda's Post-transplant Cytomegalovirus Treatment (RTTNews)
20.12.23	Takeda Canada Inks Contract With Canadian Blood Services For GLASSIA (RTTNews)
15.12.23	Takeda: CHMP Recommends Approval Of HYQVIA (RTTNews)
09.11.23	Takeda : FDA Approves Fruzaqla For Previously Treated Metastatic Colorectal Cancer (RTTNews)
28.10.23	Biotech Stocks Facing FDA Decision In November 2023 (RTTNews)
19.10.23	Takeda : Adcetris Combination Approved In Europe For Hodgkin Lymphoma Treatment (RTTNews)
18.10.23	Takeda : Phase 3 Study Of Alofisel In Complex Crohn's Perianal Fistulas Fails To Meet Main Goal (RTTNews)
18.10.23	Takeda Settles Tax Dispute With Irish Revenue Commissioners Over Break Fee Received By Shire (RTTNews)
04.10.23	Takeda's Dengue Vaccine Recommended By WHO Advisory Group (RTTNews)
03.10.23	Takeda To Voluntarily Withdraw Lung Cancer Drug Exkivity (RTTNews)
28.09.23	Takeda Receives FDA Approval For Ulcerative Colitis Therapy (RTTNews)
25.09.23	Takeda Says Japan Approves CUVITRU Subcutaneous Immunoglobulin For Patients With Agammaglobulinemia (RTTNews)
20.09.23	Takeda: FDA Accepts NDA Resubmission Of TAK-721 For Short-Term Treatment Of Eosinophilic Esophagitis (RTTNews)
13.09.23	Takeda Says FDA Accepts BLA For ENTYVIO For Maintenance Therapy In Crohn's Disease (RTTNews)
11.09.23	Takeda Reports Positive Topline Results Of Phase 2b Study Of TAK-279 For Active Psoriatic Arthritis (RTTNews)
28.08.23	ImmunoGen To Collaborate With Takeda To Develop, Commercialize Elahere In Japan (RTTNews)
17.05.23	Takeda : FDA Grants Priority Review Of TAK-755 For Treatment Of Clotting Disorder (RTTNews)
11.04.23	Takeda: HYQVIA Gets FDA Approval To Treat Primary Immunodeficiency In Children (RTTNews)
03.04.23	Innate Pharma Grants Takeda Exclusive Rights To Antibody Drug Conjugates; Stock Rises (RTTNews)
02.02.23	Takeda Pharma 9-month Net Profit Increases (RTTNews)
23.01.23	Takeda To Pay Up To $1.13 Bln To HUTCHMED For Exclusive License Of Fruquintinib Outside China (RTTNews)
19.01.23	12 Biotech Stocks Hit New Highs; Did You Make The Most Of It? (RTTNews)
11.01.23	Takeda'S Exkivity Gets Approval In China For Metastatic Lung Cancer After Chemo (RTTNews)
05.01.23	Takeda: Interim Analysis Of Phase 3 Study Supports Efficacy Of TAK-755 As Enzyme Replacement Therapy (RTTNews)
22.12.22	Astellas, 3 Other Companies Collaborate To Reduce Environmental Burden In Field Of Pharma Packaging (RTTNews)
22.12.22	Astellas, Eisai, Daiichi Sankyo and Takeda Agree to Collaborate to Reduce Environmental Burden in the Field of Pharmaceutical Packaging (PR Newswire)
13.12.22	Takeda To Acquire NDI-034858 From Nimbus (RTTNews)
08.12.22	Takeda: European Commission Grants Marketing Authorization For Dengue Vaccine, QDENGA (RTTNews)
23.11.22	Takeda : FDA Grants Priority Review Of BLA For Dengue Vaccine Candidate TAK-003 (RTTNews)
17.11.22	Takeda: Phase 3 PhALLCON Trial Meets Primary Endpoint (RTTNews)
11.11.22	Takeda: European Commission Grants Marketing Authorization For LIVTENCITY (RTTNews)
27.10.22	Takeda H1 Profit Down, Revenues Rise; Lifts FY22 Outlook - Quick Facts (RTTNews)
20.10.22	Takeda Pharma Partners With Zedira, Dr. Falk Pharma To Develop Therapy To Treat Celiac Disease (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Novartis	92.75	0.89 %	K V
Nestle	76.36	0.69 %	K V
Swisscom	506.50	0.50 %	K V
Alcon	78.00	0.49 %	K V
Roche Hldg G	252.50	0.44 %	K V
CieFinRichemont	121.90	-0.37 %	K V
Sika	226.60	-0.87 %	K V
ABB	49.02	-1.05 %	K V
Lonza Grp	517.00	-2.64 %	K V
Logitech Intl	70.06	-2.67 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Takeda Pharmaceutical Co Ltd. (spons. ADRs)

Aktien Top/Flop

Meistgelesene Nachrichten